Smith+Nephew launches CORI™ Digital Tensioner for robotically-enabled total knee arthroplasty, reducing variability when balancing the knee in surgery.
Innoblative Designs has received Breakthrough Device Designation from the U.S. FDA for SIRA™ RFA Electrosurgical Device, intended for use in breast cancer patients undergoing lumpectomy.
GE HealthCare launches Pixxoscan, its macrocyclic, non-ionic Magnetic Resonance Imaging (MRI) gadolinium-based contrast agent.
Avinger has received 510(k) clearance from the U.S. FDA for Tigereye® ST, its next-generation image-guided chronic total occlusion crossing system.
Probo Medical announces the acquisition of Ultra Select Medical, a provider of sales, service, maintenance, repair and training for ultrasound equipment.
NuVasive announces that its shareholders voted to approve the adoption of the Company’s merger agreement with Globus Medical.
Quest Diagnostics is to acquire Haystack Oncology for $450 million, which has developed a ctDNA-based technology specifically for minimal residual disease (MRD) detection.
China Nanjing-based Polymer Medical closes CNY 200 million Series B financing led by SDIC Unity capital, for the development, marketing, and production of products in the areas of general surgery, neurosurgery, and medical cosmetology.
Pattern Bioscience Closes $28.7 million Series C Financing led by Illumina Ventures and Omnimed Capital, to complete the development of its groundbreaking rapid phenotypic test platform for infectious diseases, perform clinical validation studies, and U.S. FDA review.
Israeli-based startup Neteera Technologies closes $13 million Series B financing led by Aescuvest, to accelerate sales, production and deployment of its contactless patient monitoring solution and further feature development for its proprietary medical sensing platform.
TympaHealth closes $23 million series A financing led by Octopus Ventures to expand access to its tech-enabled hearing assessment and diagnostic solution